Results 191 to 200 of about 1,164,150 (315)

Glycemic Control and Adherence to Treatment According to Personality, Self-Esteem, and Perceived Stress in Type 1 Diabetes Mellitus. [PDF]

Nurs Res Pract
Grau-Del Valle C, Marco-Expósito JF, Bosch-Sierra N, Salazar JD, García S, Solá E, Montoya-Castilla I, Morillas C, Bañuls C.   +8 more
europepmc   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

Exercise Alleviates Osteoporosis and Hyperglycemia in Type 1 Diabetes Mellitus Mice via Piezo1-Mediated Mechanotransduction. [PDF]

Biology (Basel)
Cao M, Pang F, Yu Y, Yu J, Ma S, Sun L, Fan X, Tang L.   +7 more
europepmc   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Demographic and Clinical Characteristic of Type 1 Diabetes Mellitus in Omani Children: Single Center Experience

Oman Medical Journal, 2014
Mahmood Dhahir Al-Mendalawi
doaj   +1 more source

Beyond the known: prospective research directions for the gut-brain axis in obesity and type 1 diabetes mellitus. [PDF]

Diabetol Metab Syndr
Yang D, Yang L, Yang J, Wang G.
europepmc   +1 more source

Comparative efficacy of GLP‐1 RA, tirzepatide and SGLT‐2 inhibitors in metabolic liver disease: A network meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aim Metabolic liver disease, including nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis, is a major cause of chronic liver dysfunction worldwide, creating an urgent need for effective treatments. This systematic literature review (SLR) and network meta‐analysis (NMA) systematically reviews and compares the efficacy and safety ...
Andrej Belančić, Christina Antza, Anastasios Poutachidis, Smaro Palaska, Elvira Meni Maria Gkrinia, Andrea Katrin Faour, Yusuf Ziya Sener, Seher Sener, Rehena Sultana   +8 more
wiley   +1 more source

Incidence and factors associated with hypoglycemia in newly diagnosed hospitalized children and adolescents with type 1 diabetes mellitus in China. [PDF]

Front Clin Diabetes Healthc
Li W, Qin L, Gaohui Z, Lili C, Rong G, Liping W.   +5 more
europepmc   +1 more source

Risk of injury associated with the sedative potential of second‐generation antihistamines: A nationwide retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Individual second‐generation antihistamines may possess differential sedative potential due to the variability in central histamine receptor H1 occupancy. This study aimed to evaluate whether the sedative potential of second‐generation antihistamines is associated with the risk of injury during Japan's pollen season. Methods We conducted a
Jumpei Taniguchi, Shotaro Aso, So Sato, Hideo Yasunaga   +3 more
wiley   +1 more source

Hospitalization profile among pediatric populations with type 1 diabetes mellitus in Australia: An ecological study. [PDF]

Medicine (Baltimore)
Naser AY, Alwafi H, Alsharif AA, Al Rajeh AM, Alqahtani JS, Aldhahir AM, Jarab AS, Alkhatib NS, Alhartani YJ, El-Qasem A.   +9 more
europepmc   +1 more source